Effects of diclofenac, piroxicam and α-tocopherol on monoamine-lymphopoietic interfacing in mice

Arzneimittel-Forschung/Drug Research

Volumn 54, Issue 12, 2004, Pages 847-856

  Hassanein, Nahed M A ^a   Hasan, Wafaa A ^a   Hamed, Mohamed Raouf ^a  

^a NATIONAL ORGANIZATION FOR DRUG CONTROL AND RESEARCH NODCAR   (Egypt)

Author keywords

CAS 10191 41 0; CAS 15307 79 6; CAS 36322 90 4; Diclofenac; Lymphopoiesis; Monoamines; Piroxicam; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DOPAMINE BRAIN LEVEL; DOSE TIME EFFECT RELATION; IMMUNOMODULATION; LYMPHOCYTE COUNT; LYMPHOPOIESIS; MALE; MOUSE; NEUROIMMUNOLOGY; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORADRENALIN BRAIN LEVEL; SEROTONIN BLOOD LEVEL; SEROTONIN BRAIN LEVEL; SPLEEN WEIGHT; THYMUS;

EID: 10644244286     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1297040     Document Type: Article

References (29)

1. Maestroni, G. J., Adrenergic regulation of haematopoiesis. Pharm. Res. 32, 249 (1995)
2. Vizi, E. S., Orso, E., Osipenko, O. N. et al., Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes. Neuroscience 68, 1263 (1995)
3. Artico, M., Bosco, S., Cavallotti, C. et al., Noradrenergic and cholinergic innervation of the bone marrow. Int. J. Molec. Med. 10, 77 (2002)
4. Elenkov, L. J., Wilder, R. L., Chrousos, G. P. et al., The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 52, 595 (2000)
5. Vizi, E. S., Elenkov, I. J., Nonsynaptic noradrenaline release in neuro-immune response. Acta Biol. Hung. 53, 229 (2002)
6. Brodde, O. E., Engel, G., Hoyer, D. et al., The beta-adrenergic receptor in human lymphocytes: sub classification by the use of a new radio-ligand, (+/-)-125 Iodocyanopindolol. Life Sci. 23, 2189 (1981)
7. Maisel, A. S., Harris, T., Rearden, C. A. et al., Beta-adrenergic receptors in lymphocyte subsets after exercise. Alterations in normal individyals and patients with congestive heart failure. Circulation 82, 2003 (1990)
8. Won, S. J., Chuang, Y. C., Huang, W. T. et al., Suppression of natural killer cell activity in mouse spleen lymphocytes by several dopamine receptor antagonists. Experientia 51, 343 (1995)
9. Bencsics, A., Sershen, H., Baranyi, M. et al., Dopamine, as well as norepinephrine, is a link between noradrenergic nerve terminals and splenocytes. Brain Res. 761, 236 (1997)
10. Ovadia, H., Lubetzki-Korn, I., and Abramsky, O., Dopamine receptors on isolated membranes of rat thymocyte. Ann. NY Acad. Sci. 496, 211 (1987)
11. Hassenein. N. M. A., Hamed M. R., Evaluation of the effect of non-steroidal anti-inflammatory drugs on bone marrow lymphopoiesis and the possible interaction with a-tocopherol. Egypt Pharm. J. NRC 2, 134 (2003)
12. Lorton, D., Lubahn, C., Felten, S. Y. et al., Norepinephrine content in primary and secondary lymphoid organs is altered in rats with adjuvant-induced arthritis. Mech. Ageing Dev. 94, 181 (1997)
13. 2 in interleukin-1-induced activation of norepinephrine turnover in the brain and peripheral organs of rats. J. Neurochem. 65, 2742 (1995)
14. Ciarolone, A. E., Further modification of a fluorometric method for analyzing brain amines. Microchemical. J. 23, 9 (1978)
15. Brown, C. H., Carbone, P. P., Effects of chemotherapeutic agents on normal bone marrow grown in vitro. Cancer Res. 31, 185 (1971)
16. Kamikawa, H., Hori, T., Nakane, H. et al., IL-B increases norepinephrine level in rat frontal cortex: involvement of prostanoids, NO and glutamate. Am. J. Physiol. 275, R803 (1998)
17. Sakamoto, W., Fujie, K., Nishihira, J. et al., Inhibition of PGE2 production in macrophages from vitamin E treated rats. Prostaglandins Leukot. Essent Fatty Acids 44, 89 (1991)
18. Stickel, F., Meydani, M., Wu, D. et al., Effect of vitamin E supplementation on prostaglandin concentrations in aspirin-induced acute gastric injury in aged rats. Am. J. Clin. Nutr. 66, 1218 (1997)
19. Cryer, B., Feldman, M., Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used non-steroidal anti-inflammatory drugs. Am. J. Med. 104, 413 (1998)
20. Chang, D., Baptiste, P., Schur, P. H., The effect of anti-rheumatic drugs on interlukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes. J. Rheumatol. 17, 1148 (1990)
21. Dunn, A. J., Cytokine activation of the HPA axis. Ann. NY Acad. Sci. 917, 608 (2000)
22. Akeson, A. L., Woods, C. W., Mosher, L. B. et al., Inhibition of IL-1 beta expression in THP-1 cells by probucol and tocopherol. Atherosclerosis 86, 261 (1991)
23. Devaraj, S., Li, D., Jialal, I., The effects of alpha tocopherol supplementation on monocyte function, decreased lipid oxidation, interleukin 1 β secretion and monocyte adhesion to endothelium. J. Clin. Invest. 88, 756 (1996)
24. Devaraj, S., Jialal, I., α-Tocopherol decreases interleukin-1 β release from activated human monocytes by inhibition of 5-lipoxygenase. Arterioscler. Thromb. Vasc. Biol. 19, 1125 (1999)
25. Fuchs, B. A., Campbell, K. S., Munson, A. E., Norepinephrine and serotonin content of the marine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell. Immunol. 117, 339 (1988)
26. Maestroni, G. J., Conti, A., Modulation of hematopoiesis via alpha 1-adrenergic receptor on bone marrow cells. Exp. Hematol. 22, 313 (1994)
27. Broome, C. S., Whetton, A. D., Miyan, J. A., Neuropeptide control of bone marrow neutophil production mediated by both direct and indirect effects on CFU-GM. Br. J. Haematol. 108, 140 (2000)
28. Vilcek, J., Lee, T. H., New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 66, 7313 (1991)
29. Gong, L. Daigneault, E. A., Acuff, R. V. et al., Vitamin E supplements fail to protect mice from acute MPTP nurotoxicity. Neuroreport 2, 544 (1991)